Insmed Inc (INSM)

[insm4me]

Not Sure if the settlement is good, bad or indifferent for INSM. It is only good if we announce "Phase III-enabling" clinical data SOOOON and someone opts in. That would mean instant cash($$$) and no need for dilution. Announce something tomorrow(or soon) and receive 50% reimbursement. INSTANT CASH. Hopefully this is more than wishful thinking.

IPLEX Worldwide License and Development Agreement

...Tercica (along with Ipsen, for Ipsen's Increlex territory) and Genentech will have the right to opt in...up to 90 days after Insmed provides "Phase III-enabling" clinical data... If the opt-in is exercised ... Insmed would be reimbursed 50% of its incurred development costs .. and further development costs would be shared 50:50.

GLTA(I loaded the boat, hopefully it won't sink)
TY